Product Information:

GETFIL 25mg Tablets contain Filgrastim 25mcg, not 25mg.

⚠️ Critical Clarification:

Filgrastim is dosed in micrograms (mcg), not milligrams (mg). A "25mg" label is almost certainly a typographical or labeling error. The standard strengths of filgrastim are 300mcg or 480mcg per vial/injection for subcutaneous use. Oral filgrastim does not exist—it is a biologic protein that must be administered by injection.

Therefore, GETFIL 25MG TAB is highly likely to be mislabeled. Based on the name “GETFIL” and common local naming patterns in Pakistan, this product is probably not filgrastim, but rather:

✅ Most Probable Identity: Gliclazide 25mg – a sulfonylurea antidiabetic agent commonly used in type 2 diabetes.

(“GET” may derive from “Gliclazide” and “FIL” could be a brand suffix.)

Assuming GETFIL 25mg = Gliclazide 25mg, the following description applies:

Product Full Description (English) – Assuming Gliclazide 25mg:

Product Information:

GETFIL 25mg Tablets contain Gliclazide 25mg, a second-generation sulfonylurea oral antidiabetic agent. It works by stimulating insulin release from pancreatic beta cells and may also exert mild antioxidant and antiplatelet effects.

This dose is commonly used as a starting or maintenance dose in the management of type 2 diabetes mellitus.

Uses of (GETFIL 25MG TAB):

1. Management of type 2 diabetes mellitus in adults
2. As monotherapy when diet/exercise are insufficient
3. In combination with metformin or other non-insulin agents

Key Benefits of (GETFIL 25MG TAB):

1. Once- or twice-daily dosing
2. Lower risk of hypoglycemia compared to older sulfonylureas (e.g., glibenclamide)
3. May improve platelet function and reduce microvascular complications

How To Use (GETFIL 25MG TAB):

1. Take with breakfast or the first main meal to reduce hypoglycemia risk.
2. Swallow whole with water.
3. Typical dose: 25–160mg once or twice daily (25mg is a low starting dose).
4. Do not skip meals while on this medication.

When Not to Use (GETFIL 25MG TAB):

1. Type 1 diabetes
2. Diabetic ketoacidosis
3. Severe renal or hepatic impairment
4. Hypersensitivity to gliclazide or sulfonylureas

Side Effects of (GETFIL 25MG TAB):

Common:

1. Hypoglycemia (dizziness, sweating, tremor)
2. Nausea, abdominal discomfort
3. Weight gain

Serious (rare):

1. Severe hypoglycemia (confusion, loss of consciousness)
2. Skin reactions (e.g., rash, photosensitivity)
3. Liver enzyme elevation

Dosage:

1. Starting dose: 25–80mg once daily
2. Maximum: 160mg/day in divided doses

Warnings & Precautions:

1. Avoid alcohol (increases hypoglycemia risk)
2. Monitor blood glucose regularly
3. Use caution in elderly patients

Drug Interactions:

1. Beta-blockers: Mask hypoglycemia symptoms
2. NSAIDs, sulfonamides: Increase hypoglycemia risk
3. Rifampin: Reduces efficacy

Additional Information:

Store below 30°C. Keep out of reach of children. Prescription-only in Pakistan.